Abstract

BackgroundMultiple trials have shown that in early rheumatoid arthritis (RA), both monitoring disease activity and aiming at remission, as well as using combinations of disease modifying antirheumatic drugs (DMARDs) are...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call